Zhao, Edward
Stone, Matthew R.
Ren, Xing
Guenthoer, Jamie
Smythe, Kimberly S. http://orcid.org/0000-0002-2329-8298
Pulliam, Thomas http://orcid.org/0000-0003-3511-6348
Williams, Stephen R.
Uytingco, Cedric R.
Taylor, Sarah E. B.
Nghiem, Paul http://orcid.org/0000-0003-2784-963X
Bielas, Jason H.
Gottardo, Raphael http://orcid.org/0000-0002-3867-0232
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (T32-CA080416, P01-CA225517, P30-CA015704, P30-CA015704, P01-CA225517)
U.S. Department of Health & Human Services | National Institutes of Health (F30-CA254168)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19AI128914, U19AI128914)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (S10OD028685)
Article History
Received: 10 September 2020
Accepted: 26 April 2021
First Online: 3 June 2021
Competing interests
: R.G. has received consulting income from Juno Therapeutics, Takeda, Infotech Soft, Celgene and Merck, has received research support from Janssen Pharmaceuticals and Juno Therapeutics and declares ownership in Ozette Technologies and stock ownership in 10x Genomics. S.R.W., C.R.U. and S.E.B.T. are employees of and hold shares in 10x Genomics. All other authors declare no conflicts of interest.